Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).
作者:
主题词
腺苷三磷酸(Adenosine Triphosphate);投药, 口服(Administration, Oral);动物(Animals);结合部位(Binding Sites);生物利用度(Biological Availability);结晶学, X线(Crystallography, X-Ray);药物设计(Drug Design);药物评价, 临床前(Drug Evaluation, Preclinical);脑脊髓炎, 自身免疫性, 实验性(Encephalomyelitis, Autoimmune, Experimental);酶抑制剂(Enzyme Inhibitors);人类(Humans);氢键合(Hydrogen Bonding);同工酶类(Isoenzymes);小鼠, 近交C57BL(Mice, Inbred C57BL);多发性硬化(Multiple Sclerosis);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);苯邻二甲酰亚胺类(Phthalimides);构效关系(Structure-Activity Relationship)
DOI
10.1021/acs.jmedchem.8b00085
PMID
29847724
发布时间
2019-12-10
- 浏览8

Journal of medicinal chemistry
5245-5256页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文